Chief, Division of Cancer Immunology, Department of Immunology, Nagoya University Graduate School of Medicine
Hiroyoshi Nishikawa received his MD degree from School of Medicine, Mie University (Mie, Japan) in 1995 and a PhD degree from the Graduate School of Medicine, Mie University (Mie, Japan) in 2002. He has continuously studied the role of regulatory mechanisms, particularly regulatory T cells in tumor immunity working in Dr. Lloyd J Old’s lab. at Memorial Sloan Kettering Cancer Center (New York, NY) and then Dr. Shimon Sakaguchi’s lab. at Osaka University (Osaka Japan). He is now the chief of the Division of Cancer Immunology, Research Institute / Exploratory Oncology Research and Clinical Trial Center (EPOC), at the National Cancer Center Japan and cross-appointed as Professor and chairman of Department of Immunology, Nagoya University Graduate School of Medicine. He is involved in both basic research of immune regulation, particularly immune tolerance induced by regulatory T cells, and translational research developing novel cancer immunotherapies targeting regulatory T cells.